From: Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
 | AR:ER ratio ≥ 2 | |||||
---|---|---|---|---|---|---|
 | n | Events | HR | 95% CI | P value | Model adjusted by |
Tamoxifen failure at 5Â years | 191* | 48 | 2.87 | 1.08, 7.67 | 0.04 | ER%, tumor grade |
DFS overall | 191** | 63 | 4.04 | 1.68, 9.69 | 0.002 | ER%, tumor size |
DSS overall | 190** | 49 | 2.75 | 1.11, 6.86 | 0.03 | ER%, tumor size |